Evidence map›Paper›PMID 41324141›Full record

ArticleRSC chemical biology2020

Xanthine-based photoaffinity probes allow assessment of ligand engagement by TRPC5 channels.

Claudia C Bauer, Aisling Minard, Isabelle B Pickles, Katie J Simmons, Eulashini Chuntharpursat-Bon, Matthew P Burnham, Nikil Kapur, David J Beech, Stephen P Muench, Megan H Wright and 2 more

Abstract read
In one paragraph

Article in RSC chemical biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. BTDAzo: A Photoswitchable TRPC5 Channel Activator.Angewandte Chemie (International ed. in English) · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Role of Store-Operated CaBiomolecules · 2021
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Claudia C BauerLeeds Institute of Cardiovascular and Metabolic Medicine, LIGHT Laboratories, University of Leeds Leeds LS2 9JT UK r.bon@leeds.ac.uk.
Aisling MinardLeeds Institute of Cardiovascular and Metabolic Medicine, LIGHT Laboratories, University of Leeds Leeds LS2 9JT UK r.bon@leeds.ac.uk.
Isabelle B PicklesLeeds Institute of Cardiovascular and Metabolic Medicine, LIGHT Laboratories, University of Leeds Leeds LS2 9JT UK r.bon@leeds.ac.uk.
Katie J SimmonsLeeds Institute of Cardiovascular and Metabolic Medicine, LIGHT Laboratories, University of Leeds Leeds LS2 9JT UK r.bon@leeds.ac.uk.
Eulashini Chuntharpursat-BonLeeds Institute of Cardiovascular and Metabolic Medicine, LIGHT Laboratories, University of Leeds Leeds LS2 9JT UK r.bon@leeds.ac.uk.
Matthew P BurnhamDiscovery Sciences, R&B Biopharmaceuticals, AstraZeneca Alderley Park UK.
Nikil KapurSchool of Mechanical Engineering, University of Leeds Woodhouse Lane Leeds LS2 9JT UK.
David J BeechLeeds Institute of Cardiovascular and Metabolic Medicine, LIGHT Laboratories, University of Leeds Leeds LS2 9JT UK r.bon@leeds.ac.uk.
Stephen P MuenchSchool of Biomedical Sciences, University of Leeds Woodhouse Lane Leeds LS2 9JT UK.ORCID https://orcid.org/0000-0001-6869-4414
Megan H WrightSchool of Chemistry, University of Leeds, Woodhouse Lane Leeds LS2 9JT UK.ORCID https://orcid.org/0000-0003-2731-4707
Stuart L WarrinerSchool of Chemistry, University of Leeds, Woodhouse Lane Leeds LS2 9JT UK.
Robin S BonLeeds Institute of Cardiovascular and Metabolic Medicine, LIGHT Laboratories, University of Leeds Leeds LS2 9JT UK r.bon@leeds.ac.uk.ORCID https://orcid.org/0000-0003-1733-3680

Funding

Wellcome Trust
6 · The paper itself

Abstract

TRPC1/4/5 cation channels are emerging drug targets for the treatment of, amongst others, central nervous system (CNS) disorders, kidney disease, and cardiovascular and metabolic disease. Various small-molecule TRPC1/4/5 modulators have been reported, including highly potent xanthine derivatives that distinguish between specific TRPC1/4/5 tetramers. However, tools to profile ligand engagement by TRPC1/4/5 channels in live cells are lacking. Here, we report a set of potent xanthine-based photoaffinity probes that functionally mimic the xanthines Pico145 and AM237. Using these probes, we have developed a photoaffinity labelling protocol for TRPC5 channels, providing the first method for the quantitative assessment of binding interactions of TRPC5 with small molecules in cells. This method could be important for drug discovery efforts targeting the xanthine/lipid binding site of TRPC1/4/5 channels.

Identifiers

PMID41324141
PMCPMC10655067

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.